Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease

Cites (237)

Items 201–235 of 235

1. Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases
   Tanji, Kunikazu, Maruyama, Atsushi, Odagiri, Saori, Mori, Fumiaki, Itoh, Ken, Kakita, Akiyoshi, Takahashi, Hitoshi, Wakabayashi, Koichi · 2013 · Journal of Neuropathology & Experimental Neurology
2. Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
   Michael A. Castello, John David Jeppson, Salvador Soriano · 2014 · BMC Neurology
3. Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer’s Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study
   Ruth Remington, Cynthia Bechtel, David Larsen, Annemarie Samar, Robert Page, Christopher Morrell, Thomas B. Shea · 2016 · Journal of Alzheimer s Disease
4. A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
   A. Chan, Ruth Remington, Elizabeth Kotyla, Alicia Lepore, Jill M. Zemianek, Thomas B. Shea · 2010 · The journal of nutrition health & aging
5. Cellular and Molecular Mechanisms of Action of Mitochondria-Targeted Antioxidants
   Boris A. Feniouk, Vladimir P. Skulachev · 2017 · Current Aging Science
6. Mild Cognitive Impairment and Asymptomatic Alzheimer Disease Subjects: Equivalent β-Amyloid and Tau Loads With Divergent Cognitive Outcomes
   Iacono, Diego, Resnick, Susan M., O’Brien, Richard, Zonderman, Alan B., An, Yang, Pletnikova, Olga, Rudow, Gay, Crain, Barbara, Troncoso, Juan C. · 2014 · Journal of Neuropathology & Experimental Neurology
7. The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders
   Gerwyn Morris, Ken R. Walder, Basant K. Puri, Michael Berk, Michael H. J. Maes · 2015 · Molecular Neurobiology
8. Mice Deficient in the Respiratory Chain Gene Cox6a2 Are Protected against High-Fat Diet-Induced Obesity and Insulin Resistance
   Roel Quintens, Sarvjeet Singh, Katleen Lemaire, Katrien De Bock, Mikaela Granvik, Anica Schraenen, Irene O.C.M. Vroegrijk, Veronica Costa, Pieter Van Noten, Dennis Lambrechts et al. · 2013 · PLoS ONE
9. Differences in the Cellular Uptake and Intracellular Itineraries of Amyloid Beta Proteins 40 and 42: Ramifications for the Alzheimer’s Drug Discovery
   Rajesh S. Omtri, Michael W. Davidson, Balasubramaniam Arumugam, Joseph F. Poduslo, Karunya K. Kandimalla · 2012 · Molecular Pharmaceutics
10. Lipoproteins and lipid peroxidation in Alzheimer's disease.
    Casey N. Bassett, Thomas J. Montine · 2003 · PubMed
11. Oxidative Stress and Neuronal Adaptation in Alzheimer Disease: The Role of SAPK Pathways
    Xiongwei Zhu, Arun K. Raina, Hyoung‐gon Lee, Mark Ping Chao, Akihiko Nunomura, Massimo Tabaton, Robert B. Petersen, George L. Perry, Mark A. Smith · 2003 · Antioxidants and Redox Signaling
12. Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cells
    Alain Boom, Michèle Authelet, Robert Dedecker, Christelle Frédérick, Roxane Van Heurck, Valéry Daubie, Karelle Leroy, Roland Pochet, Jean‐Pierre Brion · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
13. The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells
    Webster, M.-T., Pearce, B. R., Bowen, D. M., Francis, P. T. · 1998 · Journal of Neural Transmission
14. Caloric restriction and the precision-control of autophagy: A strategy for delaying neurodegenerative disease progression
    Claudia Ntsapi, Ben Loos · 2016 · Experimental Gerontology
15. Reversal of Metabolic Deficits by Lipoic Acid in a Triple Transgenic Mouse Model of Alzheimer's Disease: A 13C NMR Study
    H. Sancheti, K. Kanamori, Ishan Patil, Roberta Diaz-Brinton, B. Ross, E. Cadenas · 2014 · Journal of Cerebral Blood Flow and Metabolism
16. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: The preadvise trial
    For the Select Investigators, Richard J. Kryscio, Erin L. Abner, Frederick A. Schmitt, Phyllis J. Goodman, Marta S. Mendiondo, Allison Caban‐Holt, B Dennis, Melissa J. Mathews, Eric A. Klein et al. · 2012 · The journal of nutrition health & aging
17. Vitamin E and selenium supplementation in geriatric patients
    Matti Tolonen, Markku Halme, Seppo J. Sarna · 1985 · Biological Trace Element Research
18. TREATMENT OF COGNITIVE DEFICITS IN ALZHEIMER'S DISEASE: A PSYCHOPHARMACOLOGICAL REVIEW
    Carlos Campos, Nuno Rocha, Renata Teles Vieira, Nuno Rocha, Diogo Telles‐Correia, Flávia Paes, Yuan, Tifei, Antônio Egídio Nardi, Óscar Arias-Carrión, Sergio Eduardo de Carvalho Machado et al. · 2022 · PubMed
19. Mitochondria, cholesterol and amyloid β peptide: a dangerous trio in Alzheimer disease
    Anna Colell, Anna Fernández, José Carlos Fernández-Checa · 2009 · Journal of Bioenergetics and Biomembranes
20. An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.
    Xiaoling Zhou, Yifei Li, Xiaozhe Shi, Chun Ma · 2016 · PubMed Central
21. Triad of Risk for Late Onset Alzheimer’s: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex
    Yiwei Wang, Roberta Dı́az Brinton · 2016 · Frontiers in Aging Neuroscience
22. Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
    Elena A. Kosenko, Ilya Solomadin, Lyudmila A. Tikhonova, V. Prakash Reddy, Gjumrakch M. Aliev, Yury G. Kaminsky · 2013 · CNS & Neurological Disorders - Drug Targets
23. Oxidant‐induced Changes in Mitochondria and Calcium Dynamics in the Pathophysiology of Alzheimer's Disease
    Gary E. Gibson, Saravanan S. Karuppagounder, Qingli Shi · 2008 · Annals of the New York Academy of Sciences
24. Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ 4 Carriers and Adults with MildCognitive Impairment
    Angela J. Hanson, Jennifer L. Bayer, Laura D. Baker, Brenna Cholerton, Brian T. VanFossen, Emily H. Trittschuh, Robert A. Rissman, Michael Donohue, Setareh H. Moghadam, Stephen R. Plymate et al. · 2015 · Journal of Alzheimer s Disease
25. Differential distribution of cellular forms of β-amyloid precursor protein in murine glial cell cultures
    Masashi Mizuguchi, Kazuhiko Ikeda, Seung Up Kim · 1992 · Brain Research
26. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: The preadvise trial
    Richard J. Kryscio, Erin L. Abner, Frederick A. Schmitt · 2013 · The journal of nutrition health & aging
27. Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer’s Disease Pathogenesis
    Ben Ellis, Abdul Hye, Stuart G. Snowden · 2015 · Journal of Alzheimer s Disease
28. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.
    S. Cardoso, Cláudia Pereira, P. I. Moreira, Daniela M. Arduíno, A. R. Esteves, Catarina R. Oliveira · 2010 · Experimental Neurology
29. Alzheimer peptides perturb lipid-regulating enzymes
    Mark P. Mattson, Roy G. Cutler, Dong‐Gyu Jo · 2005 · Nature Cell Biology
30. Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-ß: A Protective Role of Melatonin
    Sergio Rosales‐Corral, Gabriela del Carmen López-Armas, José Alfonso Cruz-Ramos, Valery Melnikov, Dun‐Xian Tan, Lucien C. Manchester, Ruben Munoz, Russel Joseph Reiter · 2012 · International Journal of Alzheimer s Disease
31. The structure and function of ‘active zone material’ at synapses
    Joseph A. Szule, Jae Hoon Jung, U.J. McMahan · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences
32. Nerve growth factor attenuates oxidant‐induced β‐amyloid neurotoxicity in sporadic Alzheimer’s disease cybrids
    Onyango, Isaac G., Ahn, Jin‐Young, Tuttle, Jeremy B., Bennett Jr, James P., Swerdlow, Russell H. · 2010 · Journal of Neurochemistry
33. Sodium azide and 2-deoxy-D-glucose-induced cellular stress affects phosphorylation-dependent AβPP processing
    Ana Gabriela Henriques, Sara C. Domingues, Margarida Fardilha, Edgar F. da Cruz e Silva, Odete A. B. da Cruz e Silva · 2005 · Journal of Alzheimer s Disease
34. A double-blind randomized placebo-controlled clinical study to evaluate the efficacy and safety of a polyherbal formulation in geriatric age group: A phase IV clinical report
    Payel Banerjee, Soumya Maity, Tapas Das, Santasree Mazumder · 2011 · Journal of Ethnopharmacology
35. Untitled work
    Khan · 2000 · 10.1002/1531-8249(200008)48:2